Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-25

Clinical Trial Update: A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study evaluated YY-351 for efficacy and safety in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YY-351

Snippet

Sponsor: Yuyu Pharma, Inc. | Conditions: Diabetes | Phase 2 | Status: COMPLETED